GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Days Payable

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Days Payable : 48.00 (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Days Payable?

Integrated Diagnostics Holdings's average Accounts Payable for the three months ended in Jun. 2023 was $10.6 Mil. Integrated Diagnostics Holdings's Cost of Goods Sold for the three months ended in Jun. 2023 was $20.2 Mil. Hence, Integrated Diagnostics Holdings's Days Payable for the three months ended in Jun. 2023 was 48.00.

The historical rank and industry rank for Integrated Diagnostics Holdings's Days Payable or its related term are showing as below:

IDGXF' s Days Payable Range Over the Past 10 Years
Min: 36.87   Med: 49.39   Max: 98.74
Current: 43.34

During the past 12 years, Integrated Diagnostics Holdings's highest Days Payable was 98.74. The lowest was 36.87. And the median was 49.39.

IDGXF's Days Payable is ranked worse than
68.45% of 206 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs IDGXF: 43.34

Integrated Diagnostics Holdings's Days Payable declined from Jun. 2022 (52.06) to Jun. 2023 (48.00). It may suggest that Integrated Diagnostics Holdings accelerated paying its suppliers.


Integrated Diagnostics Holdings Days Payable Historical Data

The historical data trend for Integrated Diagnostics Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Days Payable Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.83 44.36 36.87 64.55 42.86

Integrated Diagnostics Holdings Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.45 48.21 47.48 48.00 -

Competitive Comparison of Integrated Diagnostics Holdings's Days Payable

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Days Payable falls into.



Integrated Diagnostics Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Integrated Diagnostics Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (10.951 + 8.791) / 2 ) / 84.053*365
=9.871 / 84.053*365
=42.86

Integrated Diagnostics Holdings's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2023 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (9.01 + 12.218) / 2 ) / 20.176*365 / 4
=10.614 / 20.176*365 / 4
=48.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Diagnostics Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021